Drug Interaction Report

Cariprazine and Ciprofloxacin: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Ciprofloxacin

No brand names on record
+

Cariprazine

Vraylar Vraylar®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 16, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 157 documented Cariprazine interactions, 148 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Effects may be stronger
The Bottom Line
Ciprofloxacin raises cariprazine levels and adds to heart-rhythm (QT) risk, so your care team will usually lower the cariprazine dose and monitor you more closely. Do not change either drug yourself; check with your pharmacist or doctor.

Here's the situation. Cariprazine (Vraylar) is broken down in your body by an enzyme called CYP3A4. The antibiotic ciprofloxacin slows that enzyme down, so cariprazine and its active byproduct can build up higher than usual. That means more of the drug hanging around, and more chance of side effects.

On top of that, both medicines can affect your heart's rhythm (something called QT prolongation). Taken together, that risk adds up, which is why this pairing gets extra attention. The good news is your care team can manage this by lowering your cariprazine dose and keeping a closer eye on you. Never stop or change either drug on your own. Just check in with your pharmacist or doctor.

Effect: Ciprofloxacin (moderate CYP3A4 inhibitor) reduces metabolism of cariprazine (CYP3A4 substrate), increasing exposure of cariprazine and its active metabolite didesmethylcariprazine (DDCAR). Both agents also prolong the QT interval, giving an additive pharmacodynamic effect and increased torsades risk.

  • Direction: increased cariprazine/DDCAR exposure; increased QT risk. Neither is a prodrug in a way that reverses this.
  • Evidence/severity: probable; major. Onset unspecified.
  • Management: Manufacturer labeling gives specific dose reductions (e.g., stable 1.5-3 mg/day to 1.5 mg every other day; 4.5-6 mg/day to 1.5 mg once daily). Re-uptitrate when the inhibitor stops. Monitor ECG/QTc, electrolytes, and for EPS/akathisia or sedation.
Onset
unspecified
Evidence
probable
Severity
Major

What happens

Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure and an increased risk of QT prolongation

Interaction Deep Dive

The combination of ciprofloxacin with cariprazine should be avoided because it can produce additive QT effects and torsade de pointes34. Because cariprazine is a CYP3A4 substrate and ciprofloxacin acts as a moderate CYP3A4 inhibitor, giving them together may raise the exposure to both cariprazine and its active metabolite, didesmethylcariprazine. For patients starting cariprazine while already on a moderate CYP3A4 inhibitor (in schizophrenia or bipolar mania), begin with 1.5 mg orally every other day, then increase to 1.5 mg orally every other day if warranted, guided by clinical response and tolerability. If a moderate CYP3A4 inhibitor is being used for bipolar depression or as adjunctive therapy in major depressive disorder (MDD), the dose is 1.5 mg orally every other day. When a moderate CYP3A4 inhibitor is added to an existing stable cariprazine regimen, dosage should be modified as follows: patients currently taking 1.5 or 3 mg once daily should have cariprazine adjusted to 1.5 mg orally every other day upon starting the moderate inhibitor, while those currently on 4.5 or 6 mg once daily should have cariprazine adjusted to 1.5 mg orally once daily. Should the moderate CYP3A4 inhibitor be stopped, the cariprazine dose may require an increase according to clinical response and tolerability1.

Why it happens (mechanism)

Inhibition of CYP3A4-mediated metabolism of cariprazine; additive QT interval prolongation

How to manage this interaction

Keep taking both exactly as prescribed unless your care team tells you otherwise. This combination is well recognized, and there are clear steps to handle it.

  • Your prescriber will likely lower your cariprazine dose while you are on ciprofloxacin, and raise it back afterward based on how you respond.
  • Your team may monitor you more closely, including checking your heart rhythm (ECG) and electrolytes.
  • Tell your doctor if you feel dizzy, faint, have a racing or irregular heartbeat, or notice more restlessness or drowsiness.

Because a short antibiotic course is often involved, ask your pharmacist whether a different antibiotic might be an option for you.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

1 report — tap to read

a) In drug interaction studies, giving cariprazine 1.5 mg/day together with erythromycin (a moderate CYP3A4 inhibitor) 500 mg twice daily for 21 days led to an increase in cariprazine AUC (0 to 24 hours) and Cmax by roughly 50% 1. In one study that included only White males receiving cariprazine 1.5 mg/day and erythromycin 500 mg twice daily (n=40), AUCs rose by 38% (cariprazine), 11% (desmethylcariprazine, an active metabolite), and 60% (didesmethylcariprazine, an active metabolite), while Cmax rose by 34%, 16%, and 62%, respectively. Tmax was not altered by coadministration with erythromycin 2.

Common questions

Can I take Cariprazine and Ciprofloxacin together?

Ciprofloxacin raises cariprazine levels and adds to heart-rhythm (QT) risk, so your care team will usually lower the cariprazine dose and monitor you more closely. Do not change either drug yourself; check with your pharmacist or doctor. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Cariprazine and Ciprofloxacin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Cariprazine and Ciprofloxacin interaction managed?

Keep taking both exactly as prescribed unless your care team tells you otherwise. This combination is well recognized, and there are clear steps to handle it. Your prescriber will likely lower your cariprazine dose while you are on ciprofloxacin, and raise it back afterward based on how you respond. Your team may monitor you more closely, including checking your heart rhythm (ECG) and electrolytes… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

From our Q&A

Real reader questions about these medications, each personally answered by our pharmacist:

Questions for your pharmacist

  • Does my dose of Cariprazine or Ciprofloxacin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (4)

  1. Product Information: VRAYLAR(R) oral capsules, cariprazine oral capsules. AbbVie Inc. (per FDA), North Chicago, IL, 2024. DailyMed
  2. Szabo M, Hujber Z, Harsanyi J, et al: Coadministration of cariprazine with a moderate CYP3A4 inhibitor in patients with schizophrenia: implications for dose adjustment and safety monitoring. Clin Pharmacokinet 2024; 63(10):1501-1510. PubMed
  3. Product Information: CIPROFLOXACIN oral tablets, ciprofloxacin oral tablets. Solco Healthcare US, LLC (per Dailymed), Somerset, NJ, 2024. DailyMed
  4. Product Information: CIPROFLOXACIN HYDROCHLORIDE oral tablets, ciprofloxacin hydrochloride oral tablets. Aurobindo Pharma USA, Inc (per Dailymed), East Windsor, NJ, 2024. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.